gossipify logo 1

A 2-year-old girl who received the most expensive medicine in the world moves her legs for the first time


Júlia Maria received a dose of Zolgensma, a R$6 million drug, to treat spinal muscular atrophy (SMA)

2-year-old girl given the most expensive medicine in the world moves her legs for the first time:
  • BY PARTICIPATING

    A 2-year-old girl who received the most expensive medicine in the world moves her legs for the first time

    A 2-year-old girl who received the most expensive medicine in the world moves her legs for the first time

  • BY PARTICIPATING

    High cholesterol: how to fight it

    High cholesterol: how to fight it

  • BY PARTICIPATING

    Does sleeping badly make you gain weight?  Understand the relationship

    Does sleeping badly make you gain weight? Understand the relationship

Two-year-old Júlia Maria, who won in court the right to receive the most expensive medicine in the world, showed improvements the week she received her dose of Zolgensma. The medicine costs around R$6 million and is used to treat spinal muscular atrophy (SMA).

Júlia and her mother, Jozelma Silva, traveled from Fortaleza (CE), where they live, to Curitiba (PR), where the girl took the medicine. After receiving the single dose, she has already shown some improvements in her condition.

According to Jozelma, he said Earth, the daughter began to move her legs and began to move. “Júlia moved her legs differently. It wasn’t her first time there, because she already moved her legs, but she didn’t make those movements to keep her legs against gravity”, she explains. Despite her movement, Júlia was unable to support her limbs, as she did in the video.

Excited, the mother hopes for further progress in her daughter’s condition, who needs help to move and breathe. “It was exciting, I believe that Júlia will do even more. Now we are very focused on seeing her well”, she said.

Remaining in Curitiba, mother and daughter will find out on Friday the 22nd if they will be able to return to Fortaleza. “[Estamos] Afraid of the medicine’s reaction, but faith in God, everything will work out and anxious to go home,” he added.

Now the next steps in Júlia’s care include physiotherapy, speech therapy, occupational therapy, in order to achieve further development of her condition and movements.

html[data-range=”xlarge”] figure image img.img-903ad4a170cdf271e803522d0772b13apn5kljni { width: 774px; height: 516px; }HTML[data-range=”large”] figure image img.img-903ad4a170cdf271e803522d0772b13apn5kljni { width: 548px; height: 365px; }HTML[data-range=”small”] figure image img.img-903ad4a170cdf271e803522d0772b13apn5kljni, html[data-range=”medium”] figure image img.img-903ad4a170cdf271e803522d0772b13apn5kljni { width: 564px; height: 376px; }HTML[data-range=”small”] .article__image-embed, html[data-range=”medium”] .article__image-embed {width: 564px; margin: 0 automatic 30px; }

Júlia Maria received the dose of Zolgensma and showed improvement in movements

What is AME?

Júlia Maria suffers from spinal muscular atrophy (SMA), a disease considered rare, degenerative and without cure. According to the Ministry of Health, AME is transmitted from parents to children and interferes with the body’s ability to produce a protein essential for the survival of neurons that control movements, such as vital involuntary gestures, such as breathing, swallowing and movement.

SMA ranges from type 0, before birth, to type 4, in the second or third decade of life, depending on the degree of muscle impairment and the age at which the first symptoms appear.

The most expensive medicines in the world

Last September, Federal Supreme Court Minister Cristiano Zanin ordered the Union to supply the drug Zolgensma to Júlia Maria. The medicine costs around R$6 million. The drug was administered last week, in Curitiba.

According to the Ministry of Health, Zolgensma has a positive effect on breathing, chewing, tongue movements, swallowing, gag reflex and speech articulation in people with SMA type I.

The medicine is administered in a single dose intravenously, unlike the other medicines already incorporated into the SUS for SMA types I and II, which are administered periodically.

Source: Terra

You may also like

Hot News

TRENDING NEWS

SUBSCRIBE

Join our community of like-minded individuals and never miss out on important news and updates again.

follow us